Fritextsökning
Innehållstyper
-
New nanotech professor to DTU
The Danish University of Technology, DTU, has appointed Kristoffer Almdal as professor to DTU Nanotech.
-
Elekta gets ok from China
The Swedish medtech comapny Elekta has received approval from the Chinese authority State Food and Drug Administration, SFDA, to sell its linear accelerator in China.
-
Abbott expands by acquisition
An acquisition gives Abbott a leadership position in another large and growing medical device segment.
-
Symphogen buys tumor blocking technology
The seller is a pioneer in developing ligand traps to treat cancer and other diseases. "An excellent fit with our scientific and strategic focus," said Kirsten ...
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Släpper aptitretande rapport
Stockholm Business Region släpper rapport om onkologi för att locka investerare till Stockholm-Uppsalaregionen. – Rapporten ska vara en aptitretare, förklarar Ylva Hultman.
-
Pledpharma förvärvar RTT
De två företagen ska tillsammans fortsätta utvecklingen av särläkemedel.
-
Blood type decide resistance to HIV
A Canadian-Swedish research team has found a blood type molecule that increases the resistance to HIV-infections.
-
Astra Zeneca lovar leverans av 2 miljarder vaccindoser mot corona
Totalt har läkemedelsföretaget ingått avtal med flera producenter och lovar nu leverans om totalt 2 miljoner vaccindoser mot det nya coronaviruset.
-
Filter tips for safer pipetting and better accuracy
Biohit has launched new Safetyspace Filter Tips that have more space between the sample and the filter than conventional filter tips usually have.
-
Pfizer drar tillbaka Allergan-budet
Läkemedelsjätten drar tillbaka jättebudet efter nya förslag mot skatteinversion för amerikanska bolag.
-
Norwegian cancer therapy leaves phase II
New clinical results from Algeta highlights the potential of Alpharadin to treat bone metastases in major cancer indications.
-
Orexo opens doors eastwards
The drug delivery company has signed a deal for selling a cancer pain treatment in China. "An ideal partner for us" says Torbjörn Bjerke, CEO of Orexo.
-
Vinnova finansierar innovation i spåren av corona
Sjuk verksamheter inom vårdsektorn tilldelas sju miljoner kronor för bland annat studier om covid-19-behandling med stamceller och framtagning av återanvändings...
-
Immunovia gör rekordstudie tillgänglig
För att validera sin produkt inledde bolaget 2016 den största kliniska studien för tidig upptäckt av ärftlig bukspottkörtelcancer hos högriskgrupper. Nu tillgän...
-
Re-painting the big pig-ture
Why do tame pigs show such variety in colouring, when their wild relatives are so plain? Swedish researchers know who is to blame. But the big question is why.
-
Will the industry follow the economic revival?
Welcome to the eleventh Biotech Forum + Scanlab Fair!
-
Multilabel plate readers with luminescence capability
The Enspire Multilabel Plate Reader platform from Perkin Elmer now features sensitive luminescence detection. The new detection capability is primarily aimed at...
-
Godkände 48 nya läkemedel 2019
Färre än 2018 men mer än dubbelt så många som år 2016.
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Raysearch tappar chef
Finanschefen lämnar medtechbolaget i april.
-
Medicon Valley cluster in brief
The Medicon Valley covers the Öresund region (Skåne and Sjaelland).
-
Time to save for survival
The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.
-
Researchers goes to the bottom of the brain
Swedish researchers have recently got new and deeper knowledge about the smallest part of the brain, the granule cells.
BREAKING